dsm-firmenich, a global leader in nutrition, health and beauty, today launches Maxilact®Next – the latest addition to its highly-valued range of efficient and pure Maxilact® lactase enzymes. With the new Maxilact®Next, dsm-firmenich introduces a lactase that produces lactose-free milk even faster, allowing its customers to achieve an additional 25% reduction in hydrolysis time. Maxilact®Next is the fastest pure lactase now available on the market which empowers lactose-free milk producers to optimize production, increase capacity and use raw materials more efficiently – all without affecting the taste of lactose-free milk products. It joins the existing Maxilact® range, an extensive portfolio based on the company’s more than 50 years’ experience leading lactose-free dairy production.
Unlocking potential in the lactose-free dairy market
With 70% of consumers worldwide unable to properly digest lactose, lactose-free products are vital for ensuring everyone can fully enjoy great tasting, nutritious dairy products. Forecasts predict that lactose-free dairy will achieve a CAGR more than double that of regular dairy between 2022 and 2026, eventually exceeding a value of €10.6 billion. This creates fresh opportunities for dairy producers while also emphasizing the need for a swifter and more efficient production process. Manufacturers require first-class lactase solutions to optimize their raw material usage, increase yield and productivity and maintain the highest quality standards.
“We’re proud to introduce Maxilact®Next to the market – the fastest, purest, most efficient lactase enzyme solution in our portfolio yet,” comments Rodolfo Garza, Global Business Development Manager Milk & Plant-Based Alternatives at dsm-firmenich. “In the current market context, efficiency is crucial to keep up with demand and stay cost effective. Our Maxilact® range delivers optimized capacity without significant capex investment while maintaining the high quality that consumers expect. Maxilact®Next is a great example of a game-changing lactase solution which truly addresses a market pain point.”
Strengthening a world-leading portfolio
dsm-firmenich’s extensive selection of Maxilact® enzymes along with its portfolio of cultures, probiotics, vitamins, minerals and more allows manufacturers to produce lactose-free products that are not only more efficient but also more delicious and nutritious, catering to the ever-expanding global consumer base.
Partnering with dsm-firmenich means unlocking expert support across the entire dairy value chain. From R&D to marketing and regulatory support, we create innovative and tailored solutions for regional market preferences. With dsm-firmenich, manufacturers’ visions become a reality – quickly, smoothly, and sustainably.
To discover more about the capabilities of Maxilact®Next, visit https://www.dsm.com/food-beverage/en_US/markets/dairy/fresh-dairy/maxilact-next.html
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
